Multiple malignancies amongst cancer survivors in the Netherlands since 1989 - implications for surveillance

作者: Lifang Liu

DOI:

关键词: Relative survivalSkin cancerInternal medicineEpidemiology of cancerCancerLife expectancySecond cancerMetastasisOncologyMedicineDemographyQuality of life

摘要: textabstractEarly detection of cancer as well advances in therapy and supportive care have resulted a prolonged survival period time after cancer. In the Netherlands 5-year relative survival for all types cancers combined increased from 47% 1989-1993 to 59% 2004-2008. Once patients survived long enough (i.e. 10 years) since diagnosis their cancer, their life expectancy usually becomes almost same people without a (conditional 5-year survival>95%). A Cancer scenario Report expected prevalence of second increase 14,000 1985 24,000 (excl. skin cancer) in 2000 when assuming an average duration by 1% per annum. The Signallling report 2004 Dutch Society estimated prevalence multiple malignancies (MMs) reach around 100,000 cases 2015 due a twofold number survivors 2005. Since may impair survival is likely affect quality life amongst we should be interested in prevention early its undoubtedly more complex treatment. MMs are defined two or primary occurring individual that are neither extension, nor recurrence, metastasis first tumor1.

参考文章(242)
Maryska L. G. Janssen-Heijnen, Saskia Houterman, Valery E. P. P. Lemmens, Marieke W. J. Louwman, Jan Willem W. Coebergh, Age and co-morbidity in cancer patients: a population-based approach. Cancer treatment and research. ,vol. 124, pp. 89- 107 ,(2005) , 10.1007/0-387-23962-6_5
H Gogas, P Skandalakis, J Gogas, C Markopoulos, Bilateral breast cancer American Surgeon. ,vol. 59, pp. 733- 735 ,(1993)
Tartter Pi, Brower St, Gustafsson A, Lesnick G, Prognosis of patients with bilateral carcinoma of the breast. Journal of The American College of Surgeons. ,vol. 178, pp. 111- 116 ,(1994)
Howard K. Koh, Donald R. Miller, Alan C. Geller, Richard W. Clapp, Mary Beth Mercer, Robert A. Lew, Who discovers melanoma? Patterns from a population-based survey. Journal of The American Academy of Dermatology. ,vol. 26, pp. 914- 919 ,(1992) , 10.1016/0190-9622(92)70132-Y
Alvaro Figueredo, , R Bryan Rumble, Jean Maroun, Craig C Earle, Bernard Cummings, Robin McLeod, Lisa Zuraw, Caroline Zwaal, Follow-up of patients with curatively resected colorectal cancer: a practice guideline BMC Cancer. ,vol. 3, pp. 26- 26 ,(2003) , 10.1186/1471-2407-3-26
K.K.H. Aben, L.V. van de Poll-Franse, S. Siesling, O. Visser, H.E. Karim-Vos, T.K. Luth, R.A. Damhuis, [Adult cancer patients are surviving longer in the Netherlands: 5-year survival rate increased by 12% between the periods 1989-1993 and 2004-2008]. Nederlands Tijdschrift voor Geneeskunde. ,vol. 155, ,(2011)
TNM classification of malignant tumours Published in <b>2010</b> in Chichester, West Sussex, UK ;Hoboken, NJ by Wiley-Blackwell. ,(1987) , 10.1007/978-3-642-82982-6
Robert Benamouzig, Jacques Deyra, Antoine Martin, Bernard Girard, Eric Jullian, Benoit Piednoir, Daniel Couturier, Thierry Coste, Julian Little, Stanislas Chaussade, Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial. Gastroenterology. ,vol. 125, pp. 328- 336 ,(2003) , 10.1016/S0016-5085(03)00887-4
Rajesh P. Dikshit, Paolo Boffetta, Christine Bouchardy, Franco Merletti, Paolo Crosignani, Teresa Cuchi, Eva Ardanaz, Paul Brennan, Risk factors for the development of second primary tumors among men after laryngeal and hypopharyngeal carcinoma. Cancer. ,vol. 103, pp. 2326- 2333 ,(2005) , 10.1002/CNCR.21051